TD Cowen Maintains Outperform on Eli Lilly, Raises Price Target to $500
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Steve Scala maintains an Outperform rating on Eli Lilly (NYSE:LLY) and raises the price target from $430 to $500.
May 23, 2023 | 11:26 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TD Cowen analyst Steve Scala maintains an Outperform rating on Eli Lilly and raises the price target from $430 to $500.
The news of TD Cowen maintaining an Outperform rating on Eli Lilly and raising the price target from $430 to $500 is positive for the company's stock. This indicates that the analyst believes the stock will outperform the market and has a higher price target, which could attract more investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100